Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
642.50
Change Change %
-3.70 -0.57%

Updated:18 Sep, 2018, 15:59 PM IST

BSE
642.30
Change Change %
-3.85 -0.60%

Updated:18 Sep, 2018, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Bank of America Merrill Lynch
N/A
23-12-2016 Buy 610.00 N/A
N/A
Closed Long (1Y)
23-12-2017

Bank of America Merrill Lynch maintains buy on Sun Pharma

Bank of America Merrill Lynch has maintained its buy call on Sun Pharma on the back of attractive valuations. However, it prefers Lupin over Sun Pharma. It adds that Odomzo acquisition will strengthen specialty portfolio. Meanwhile, the brokerage does not see a re-rating on Sun Pharma in the near-term.

Top